Numerous studies have demonstrated that RhoA/ROCK signaling is involved in actin polymerization and accelerates F-actin rearrangement, which enables tumor cells to traverse the ECM, thereby increasing the invasive capacity of BC cells [53, 54]. The gene discussed is RHOA; the disease is breast cancer.